受强制性开放获取政策约束的文章 - Elisabeth Kapaki了解详情
无法在其他位置公开访问的文章：1 篇
Motor and nonmotor features of carriers of the p. A53T alpha‐synuclein mutation: a longitudinal study
D Papadimitriou, R Antonelou, M Miligkos, M Maniati, N Papagiannakis, ...
Movement Disorders 31 (8), 1226-1230, 2016
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：13 篇
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
强制性开放获取政策： US National Institutes of Health
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
强制性开放获取政策： US National Institutes of Health
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
强制性开放获取政策： Research Foundation (Flanders)
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, National Health …
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
强制性开放获取政策： US National Institutes of Health, Banking Foundation "la Caixa", UK Medical …
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ...
Biomarkers in medicine 10 (1), 19-34, 2016
强制性开放获取政策： Academy of Finland, European Commission, Netherlands Organisation for Health …
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease-A consensus report
A Wallin, E Kapaki, M Boban, S Engelborghs, DM Hermann, B Huisa, ...
BMC neurology 17, 1-12, 2017
强制性开放获取政策： Research Foundation (Flanders), Swedish Research Council
Association study of cholesterol-related genes in Alzheimer’s disease
MA Wollmer, K Sleegers, M Ingelsson, C Zekanowski, N Brouwers, ...
Neurogenetics 8, 179-188, 2007
强制性开放获取政策： Research Foundation (Flanders)
Circulating brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease
S Ravanidis, A Bougea, N Papagiannakis, M Maniati, C Koros, AM Simitsi, ...
Movement disorders 35 (3), 457-467, 2020
强制性开放获取政策： European Commission, Michael J Fox Foundation
The central biobank and virtual biobank of BIOMARKAPD: a resource for studies on neurodegenerative diseases
BLR Reijs, CE Teunissen, N Goncharenko, F Betsou, K Blennow, ...
Frontiers in neurology 6, 216, 2015
强制性开放获取政策： Swiss National Science Foundation, Research Foundation (Flanders), Fonds de …
Does caffeine consumption modify cerebrospinal fluid amyloid-β levels in patients with Alzheimer’s disease?
M Travassos, I Santana, I Baldeiras, M Tsolaki, O Gkatzima, G Sermin, ...
Journal of Alzheimer's Disease 47 (4), 1069-1078, 2015
强制性开放获取政策： Danish Council for Strategic Research, Fundação para a Ciência e a …
A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing
AS Denommé-Pichon, L Matalonga, E de Boer, A Jackson, E Benetti, ...
Genetics in Medicine 25 (4), 100018, 2023
强制性开放获取政策： UK Medical Research Council, European Commission, Government of Spain
出版信息和资助信息由计算机程序自动确定